Rallybio Corp (RLYB) Stock Analysis
Verdict: HOLD
Aggressive insider buying and a J&J partnership collide with a sharp analyst sentiment collapse, making this a high-stakes binary play.
Investment score: 64/100
Analysis as of
Is Rallybio Corp stock worth reviewing? The TradeMates thesis
RLYB is a high-alpha biotech play where insider conviction is fighting a bearish analyst consensus. The model opts for HOLD as it waits for the resolution of this sentiment divergence.
7-factor investment score
- Valuation: 55/100 (weight 20%)
- Financial Health: 40/100 (weight 15%)
- Technical Momentum: 85/100 (weight 15%)
- Earnings Quality: 60/100 (weight 15%)
- Insider Sentiment: 95/100 (weight 10%)
- Analyst Consensus: 30/100 (weight 10%)
- Risk-Adjusted Return: 60/100 (weight 15%)
Rallybio Corp opportunities and risks
What speaks for RLYB
- Extreme Insider Conviction
What speaks against RLYB
- Rapid Institutional Exit/Downgrades
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| RLYB | n/a | 88.1x | n/a | 99.7% | -911.1% | -36.5% |
| CUE | n/a | 1.6x | n/a | 99.8% | -59.6% | -48.1% |
| CTOR | n/a | 13.6x | n/a | 80.1% | -757.6% | -22.2% |
| MCRB | n/a | 65.2x | n/a | -20.9% | -4088.8% | -56.7% |
| MAIA | n/a | 0.0x | n/a | 0.0% | 0.0% | -41.6% |
| ACRV | n/a | 0.0x | n/a | 0.0% | 0.0% | -119.0% |
| Peer median | n/a | 1.6x | n/a | 0.0% | -59.6% | -48.1% |
Frequently asked questions about Rallybio Corp (RLYB)
Is RLYB stock a good investment?
The TradeMates model rates Rallybio Corp as HOLD with an investment score of 64/100. RLYB is a high-alpha biotech play where insider conviction is fighting a bearish analyst consensus. The model opts for HOLD as it waits for the resolution of this sentiment divergence. This is algorithmic model output, not personal investment advice.
Is RLYB stock a buy?
The TradeMates model verdict for RLYB is HOLD with an investment score of 64/100. Treat this as a model signal to review, not a personal buy recommendation.